Maternal serum CFHR4 protein as a potential non-invasive marker of ventricular septal defects in offspring: evidence from a comparative proteomics study
ConclusionsSubsequent logistic regression and receiver operating characteristic analysis suggested maternal serum CFHR4 as a promising biomarker of fetal VSD. Further studies are warranted to verify the findings.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research
More News: Biochemistry | Cardiology | Genetics | Heart | Hole in the Heart | Study | Ventricular Septal Defect | Women